schizophrenia

News and resources

Month: February 2021

Feb 25 2021

Phase II Results Promising for New Schizophrenia Drug Combo

by Clinical Editor

No Comments

Phase II results appear promising for a new combination treatment for schizophrenia. Findings from previous studies have shown that the muscarinic receptor agonist xanomeline could be used as a novel...

Feb 25 2021

Uncategorized

Seeing schizophrenia: X-rays shed light on neural differences, point toward treatment

by Clinical Editor

No Comments

Schizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person’s thoughts, feelings and behavior. Symptoms include delusions, …

Feb 25 2021

Uncategorized

Powerful X-Rays Reveal Unique Differences in Neurons From People With Schizophrenia

by Clinical Editor

No Comments

Capturing details of brain cells on a nanometre scale, researchers have uncovered evidence that the neurons of people with schizophrenia could have unique differences in thickness and curvature, and …

Feb 25 2021

Uncategorized

Researchers use powerful X-rays to analyze brain tissues of schizophrenia patients

by Clinical Editor

No Comments

Schizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person’s thoughts, feelings and behavior.

Feb 25 2021

Uncategorized

PureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia

by Clinical Editor

No Comments

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, develo …

Feb 24 2021

Uncategorized